Clopidogrel-associated hypoglycaemia and alternative antiplatelet therapy: a real-world, pharmacovigilance study

Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):8-9. doi: 10.1093/ehjcvp/pvac050.
No abstract available

Keywords: Antiplatelet therapy; Clopidogrel; Drug safety; Hypoglycaemia; Insulin autoimmune syndrome; Pharmacovigilance study.

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Clopidogrel / adverse effects
  • Humans
  • Hypoglycemia*
  • Pharmacovigilance
  • Platelet Aggregation Inhibitors* / adverse effects
  • Prasugrel Hydrochloride

Substances

  • Clopidogrel
  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride